Expression of cell adhesion molecules and prognosis in breast cancer

Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome

(2011) R. Yerushalmi et al.   ANNALS OF ONCOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1

(2011) Manfred Schmitt et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients

(2010) Johanna G. H. van Nes et al.   BREAST CANCER RESEARCH AND TREATMENT

The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients with Early Breast Cancer

(2010) E. M. de Kruijf et al.   CLINICAL CANCER RESEARCH

Breast Cancer Prognosis and Occult Lymph Node Metastases, Isolated Tumor Cells, and Micrometastases

(2010) M. de Boer et al.   JNCI-Journal of the National Cancer Institute

Molecular mechanisms controlling E-cadherin expression in breast cancer

(2009) Somesh Baranwal et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Cell Adhesion Molecules: Role and Clinical Significance in Cancer

(2009) Nektaria Makrilia et al.   CANCER INVESTIGATION

MammaPrint™ 70-gene signature: another milestone in personalized medical care for breast cancer patients

(2009) Elzbieta A Slodkowska et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Cadherin switching

(2008) M. J. Wheelock et al.   JOURNAL OF CELL SCIENCE

Molecular Basis of Metastasis

(2008) Anne C. Chiang et al.   NEW ENGLAND JOURNAL OF MEDICINE